CymitQuimica logo

CAS 923288-90-8

:

Nilotinib hcl monohydrate

Description:
Nilotinib hydrochloride monohydrate is a small molecule tyrosine kinase inhibitor primarily used in the treatment of chronic myeloid leukemia (CML). It is characterized by its ability to selectively inhibit the BCR-ABL fusion protein, which is responsible for the proliferation of cancer cells in CML. The compound is typically presented as a white to off-white crystalline powder and is soluble in water, which facilitates its administration in a clinical setting. Its chemical formula includes a hydrochloride salt and a monohydrate form, indicating the presence of one water molecule per formula unit. Nilotinib exhibits a high affinity for the ATP-binding site of the BCR-ABL protein, which enhances its efficacy compared to other treatments. The pharmacokinetics of nilotinib show a relatively long half-life, allowing for once or twice daily dosing. Common side effects may include nausea, fatigue, and hematological abnormalities, necessitating regular monitoring of blood counts during treatment. Overall, nilotinib hydrochloride monohydrate represents a significant advancement in targeted cancer therapy.
Formula:C28H22F3N7OHClH2O
Synonyms:
  • Nilotinib hydrochloride monohydrate
  • Nilotinib monohydrochloride monohydrate
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 12 products.